Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-6-24
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0001-5555
pubmed:author
pubmed:issnType
Print
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
433-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20574622-Anticoagulants, pubmed-meshheading:20574622-Antineoplastic Agents, pubmed-meshheading:20574622-Antiphospholipid Syndrome, pubmed-meshheading:20574622-Biopsy, pubmed-meshheading:20574622-Calcium Channel Blockers, pubmed-meshheading:20574622-Dendritic Cells, pubmed-meshheading:20574622-Drug Therapy, Combination, pubmed-meshheading:20574622-Hand, pubmed-meshheading:20574622-Humans, pubmed-meshheading:20574622-Immunotherapy, pubmed-meshheading:20574622-Interferon-alpha, pubmed-meshheading:20574622-Lymphatic Metastasis, pubmed-meshheading:20574622-Male, pubmed-meshheading:20574622-Melanoma, pubmed-meshheading:20574622-Middle Aged, pubmed-meshheading:20574622-Necrosis, pubmed-meshheading:20574622-Polyethylene Glycols, pubmed-meshheading:20574622-Recombinant Proteins, pubmed-meshheading:20574622-Skin, pubmed-meshheading:20574622-Toes, pubmed-meshheading:20574622-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Skin necrosis revealing antiphospholipid syndrome during immunotherapy for melanoma.
pubmed:publicationType
Letter, Case Reports